Download PDF
Horm Metab Res 2013; 45(02): 118-123
DOI: 10.1055/s-0032-1331745
Review
© Georg Thieme Verlag KG Stuttgart · New York

Screening for Cushing’s Syndrome: New Immunoassays Require Adequate Normative Data

T. Deutschbein
1   Department of Internal Medicine I, Endocrine and Diabetes Unit, University Hospital, Würzburg, Germany
,
S. Petersenn
2   ENDOC Center for Endocrine Tumors, Hamburg, Germany
› Author Affiliations
Further Information

Publication History

received 05 September 2012

accepted 26 November 2012

Publication Date:
15 February 2013 (online)

Also available at
    Permissions and Reprints

Abstract

Cushing’s syndrome results from chronic inappropriate exposure to excessive glucocorticoid concentrations. Low-dose dexamethasone suppression, late-night salivary cortisol, and 24-h urinary free cortisol are regarded as screening tests of first choice. Consequently, measurement of circulating cortisol (e. g., in serum, saliva, and urine) is mandatory in the diagnostic workup of suspected patients. The particular analytical procedure needs to be chosen carefully. Antibody-based immunoassays offer several potential advantages: they require small volumes and are widely available, relatively cheap, and easy to handle. Modern (ideally automated) systems also have a rapid turnaround time on a large number of samples and demonstrate high analytical accuracy. However, there are some important pitfalls. Inadequate standardization and poor interlaboratory performance remain problematic and precise reference ranges are lacking for some of the newer assays. Immunoassays are also susceptible to error due to cross-reactivity with cortisol metabolites or exogenous glucocorticoids. In contrast, steroid analysis by modern chromatographic and mass spectrometric techniques is largely independent from such interference and is therefore regarded as diagnostic gold standard. To date, however, these procedures are costly, time-consuming, and at least at present restricted to a limited number of specialized centers. This review puts special emphasis on the potential advantages of salivary cortisol analysis by immunoassays. It has been shown in numerous studies that such an approach allows excellent identification of hypercortisolemic states. In this context, use of automated systems may allow for broader use of this diagnostic tool.

Key words

cortisol - Cushing’s disease - glucocorticoids - hypercortisolism - measurement - reference range
 

  • References

  • 1 Boscaro M, Barzon L, Sonino N. The diagnosis of Cushing’s syndrome. Atypical presentations and laboratory shortcomings. Arch Intern Med 2000; 160: 3045-3053
    CrossrefPubMedGoogle Scholar
  • 2 Newell-Price J, Bertagna X, Grossman AB, Nieman LK. Cushing’s syndrome. Lancet 2006; 367: 1605-1617
    CrossrefPubMedGoogle Scholar
  • 3 Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM. The diagnosis of Cushing’s syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2008; 93: 1526-1540
    Google Scholar
  • 4 Elamin MB, Hassan Murad M, Mullan R, Erickson D, Harris K, Nadeem S, Ennis R, Erwin PJ, Montori VM. Accuracy of diagnostic tests for Cushing’s syndrome. A systematic review and meta-analyses. J Clin Endocrinol Metab 2008; 93: 1553-1562
    CrossrefPubMedGoogle Scholar
  • 5 Gatti R, Antonelli G, Prearo M, Spinella P, Cappellin E, de Palo EF. Cortisol assays and diagnostic laboratory procedures in human biological fluids. Clin Biochem 2009; 42: 1205-1217
    CrossrefPubMedGoogle Scholar
  • 6 Raff H. Utility of salivary cortisol measurements in Cushing’s syndrome and adrenal insufficiency. J Clin Endocrinol Metab 2009; 94: 3647-3655
    CrossrefPubMedGoogle Scholar
  • 7 Alexandraki KI, Grossman AB. Is urinary free cortisol of value in the diagnosis of Cushing’s syndrome?. Curr Opin Endocrinol Diabetes Obes 2011; 18: 259-263
    CrossrefPubMedGoogle Scholar
  • 8 Deutschbein T, Unger N, Hinrichs J, Walz MK, Petersenn S. Late-night and low-dose dexamethasone-suppressed cortisol in saliva and serum for the diagnosis of cortisol-secreting adrenal adenomas. Eur J Endocrinol 2009; 161: 747-753
    CrossrefPubMedGoogle Scholar
  • 9 Deutschbein T, Broecker-Preuss M, Hartmann MF, Althoff R, Wudy SA, Mann K, Petersenn S. Measurement of urinary free cortisol by current immunoassays: Need for sex-dependent reference ranges to define hypercortisolism. Horm Metab Res 2011; 43: 714-719
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Deutschbein T, Broecker-Preuss M, Flitsch J, Jaeger A, Althoff R, Walz MK, Mann K, Petersenn S. Salivary cortisol as a diagnostic tool for Cushing’s syndrome and adrenal insufficiency: improved screening by an automatic immunoassay. Eur J Endocrinol 2012; 166: 613-618
    CrossrefPubMedGoogle Scholar
  • 11 Lewis JG. Steroid analysis in saliva: an overview. Clin Biochem Rev 2006; 27: 139-146
    PubMedGoogle Scholar
  • 12 Groschl M. Current status of salivary hormone analysis. Clin Chem 2008; 54: 1759-1769
    CrossrefPubMedGoogle Scholar
  • 13 Wood P. Salivary steroid analysis – research or routine?. Ann Clin Biochem 2009; 46: 183-196
    CrossrefPubMedGoogle Scholar
  • 14 Hamrahian AH, Oseni TS, Arafah BM. Measurements of serum free cortisol in critically ill patients. N Engl J Med 2004; 350: 1629-1638
    CrossrefPubMedGoogle Scholar
  • 15 Klose M, Lange M, Rasmussen AK, Skakkebaek NE, Hilsted L, Haug E, Andersen M, Feldt-Rasmussen U. Factors influencing the adrenocorticotropin test: role of contemporary cortisol assays, body composition, and oral contraceptive agents. J Clin Endocrinol Metab 2007; 92: 1326-1333
    CrossrefPubMedGoogle Scholar
  • 16 Carroll T, Raff H, Findling JW. Late-night salivary cortisol measurement in the diagnosis of Cushing’s syndrome. Nat Clin Pract Endocrinol Metab 2008; 4: 344-350
    CrossrefPubMedGoogle Scholar
  • 17 Nunes ML, Vattaut S, Corcuff JB, Rault A, Loiseau H, Gatta B, Valli N, Letenneur L, Tabarin A. Late-night salivary cortisol for diagnosis of overt and subclinical Cushing’s syndrome in hospitalized and ambulatory patients. J Clin Endocrinol Metab 2009; 79: 1532-1539
    PubMedGoogle Scholar
  • 18 Carroll T, Raff H, Findling JW. Late-night salivary cortisol for the diagnosis of Cushing syndrome: a meta-analysis. Endocr Pract 2009; 15: 335-342
    CrossrefPubMedGoogle Scholar
  • 19 Raff H, Raff JL, Findling JW. Late-night salivary cortisol as a screening test for Cushing’s syndrome. J Clin Endocrinol Metab 1998; 83: 2681-2686
    CrossrefPubMedGoogle Scholar
  • 20 Castro M, Elias PC, Quidute AR, Halah FP, Moreira AC. Outpatient screening for Cushing’s syndrome: the sensitivity of the combination of circadian rhythm and overnight dexamethasone suppression salivary cortisol tests. J Clin Endocrinol Metab 1999; 84: 878-882
    CrossrefPubMedGoogle Scholar
  • 21 Papanicolaou DA, Mullen N, Kyrou I, Nieman LK. Nighttime salivary cortisol: a useful test for the diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab 2002; 87: 4515-4521
    CrossrefPubMedGoogle Scholar
  • 22 Putignano P, Toja P, Dubini A, Pecori Giraldi F, Corsello SM, Cavagnini F. Midnight salivary cortisol versus urinary free and midnight serum cortisol as screening tests for Cushing’s syndrome. J Clin Endocrinol Metab 2003; 88: 4153-4157
    CrossrefPubMedGoogle Scholar
  • 23 Yaneva M, Mosnier-Pudar H, Dugue MA, Grabar S, Fulla Y, Bertagna X. Midnight salivary cortisol for the initial diagnosis of Cushing’s syndrome of various causes. J Clin Endocrinol Metab 2004; 89: 3345-3351
    CrossrefPubMedGoogle Scholar
  • 24 Trilck M, Flitsch J, Ludecke DK, Jung R, Petersenn S. Salivary cortisol measurement – a reliable method for the diagnosis of Cushing’s syndrome. Exp Clin Endocrinol Diabetes 2005; 113: 225-230
    Article in Thieme ConnectPubMedGoogle Scholar
  • 25 Viardot A, Huber P, Puder JJ, Zulewski H, Keller U, Muller B. Reproducibility of nighttime salivary cortisol and its use in the diagnosis of hypercortisolism compared with urinary free cortisol and overnight dexamethasone suppression test. J Clin Endocrinol Metab 2005; 90: 5730-5736
    CrossrefPubMedGoogle Scholar
  • 26 Doi M, Sekizawa N, Tani Y, Tsuchiya K, Kouyama R, Tateno T, Izumiyama H, Yoshimoto T, Hirata Y. Late-night salivary cortisol as a screening test for the diagnosis of Cushing’s syndrome in Japan. Endocr J 2008; 55: 121-126
    CrossrefPubMedGoogle Scholar
  • 27 Cardoso EM, Arregger AL, Tumilasci OR, Contreras LN. Diagnostic value of salivary cortisol in Cushing’s syndrome (CS). Clin Endocrinol (Oxf) 2009; 70: 516-521
    CrossrefPubMedGoogle Scholar
  • 28 Baid SK, Sinaii N, Wade M, Rubino D, Nieman LK. Radioimmunoassay and tandem mass spectrometry measurement of bedtime salivary cortisol levels: a comparison of assays to establish hypercortisolism. J Clin Endocrinol Metab 2007; 92: 3102-3107
    CrossrefPubMedGoogle Scholar
  • 29 Zerikly RK, Amiri L, Faiman C, Gupta M, Singh RJ, Nutter B, Kennedy L, Hatipoglu B, Weil RJ, Hamrahian AH. Diagnostic characteristics of late-night salivary cortisol using liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab 2010; 95: 4555-4559
    CrossrefPubMedGoogle Scholar
  • 30 van Aken MO, Romijn JA, Miltenburg JA, Lentjes EG. Automated measurement of salivary cortisol. Clin Chem 2003; 49: 1408-1409
    CrossrefPubMedGoogle Scholar
  • 31 Vogeser M, Durner J, Seliger E, Auernhammer C. Measurement of late-night salivary cortisol with an automated immunoassay system. Clin Chem Lab Med 2006; 44: 1441-1445
    PubMedGoogle Scholar
  • 32 Sereg M, Toke J, Patócs A, Varga I, Igaz P, Szücs N, Horányi J, Pusztai P, Czirják S, Gláz E, Rácz K, Tóth M. Diagnostic performance of salivary cortisol and serum osteocalcin measurements in patients with overt and subclinical Cushing’s syndrome. Steroids 2011; 76: 38-42
    CrossrefPubMedGoogle Scholar
  • 33 Yaneva M, Kirilov G, Zacharieva S. Midnight salivary cortisol, measured by highly sensitive electrochemiluminescence immunoassay, for the diagnosis of Cushing’s syndrome. Central Eur J Med 2009; 4: 59-64
    PubMedGoogle Scholar
  • 34 Beko G, Varga I, Glaz E, Sereg M, Feldman K, Toth M, Racz K, Patocs A. Cutoff values of midnight salivary cortisol for the diagnosis of overt hypercortisolism are highly influenced by methods. Clin Chim Acta 2010; 411: 364-367
    CrossrefPubMedGoogle Scholar
  • 35 Carrozza C, Corsello SM, Paragliola RM, Ingraudo F, Palumbo S, Locantore P, Sferrazza A, Pontecorvi A, Zuppi C. Clinical accuracy of midnight salivary cortisol measured by automated electrochemiluminescence immunoassay method in Cushing’s syndrome. Ann Clin Biochem 2010; 47: 228-232
    CrossrefPubMedGoogle Scholar
  • 36 Jeyaraman K, Ammini AC, Nandita G, Dwivedi SN. Late-night salivary cortisol in normal subjects and in patients with Cushing’s syndrome. Postgrad Med J 2010; 86: 399-404
    CrossrefPubMedGoogle Scholar
  • 37 Sakihara S, Kageyhama K, Oki Y, Doi M, Iwasaki Y, Takayasu S, Moriyama T, Terui K, Nibawara T, Hirata Y, Hashimoto K, Suda T. Evaluation of plasma, salivary, and urinary cortisol levels for diagnosis of Cushing’s syndrome. Endocr J 2010; 57: 331-337
    CrossrefPubMedGoogle Scholar
  • 38 Belaya ZE, Iljin AV, Melnichenko GA, Rozhinskaya LY, Dragunova NV, Dzeranova LK, Butrova SA, Troshina EA, Dedov II. Diagnostic performance of late-night salivary cortisol measured by automated electrochemiluminescence immunoassay in obese and overweight patients referred to exclude Cushing’s syndrome. Endocrine 2012; 41: 494-500
    CrossrefPubMedGoogle Scholar
  • 39 Carrasco CA, Garcia M, Goycoolea M, Cerda J, Bertherat J, Padilla O, Meza D, Wohllk N, Quiroga T. Reproducibility and performance of one or two samples of salivary cortisol in the diagnosis of Cushing’s syndrome using an automated immunoassay system. Endocrine 2012; 41: 487-493
    CrossrefPubMedGoogle Scholar
  • 40 Barrou Z, Guiban D, Maroufi A, Fournier C, Dugue MA, Luton JP, Thomopoulos P. Overnight dexamethasone suppression test: comparison of plasma and salivary cortisol measurement for the screening of Cushing’s syndrome. Eur J Endocrinol 1996; 134: 93-96
    CrossrefPubMedGoogle Scholar
  • 41 Raff H, Homar PJ, Burns EA. Comparison of two methods for measuring salivary cortisol. Clin Chem 2002; 48: 207-208
    PubMedGoogle Scholar
  • 42 Roberts RF, Roberts WL. Performance characteristics of five automated serum cortisol immunoassays. Clin Biochem 2004; 37: 489-493
    CrossrefPubMedGoogle Scholar
  • 43 Holder G. External quality assessment of urinary-free cortisol measurement in the UK against a gas chromatography mass spectroscopy reference method. Ann Clin Biochem 1995; 32: 84-90
    PubMedGoogle Scholar
  • 44 Turpeinen U, Markkanen H, Valimaki M, Stenman UH. Determination of urinary free cortisol by HPLC. Clin Chem 1997; 43: 1386-1391
    PubMedGoogle Scholar
  • 45 Wood L, Ducroq DH, Fraser HL, Gillingwater S, Evans C, Pickett AJ, Rees DW, John R, Turkes A. Measurement of urinary free cortisol by tandem mass spectrometry and comparison with results obtained by gas chromatography-mass spectrometry and two commercial immunoassays. Ann Clin Biochem 2008; 45: 380-388
    CrossrefPubMedGoogle Scholar
  • 46 Fong BM, Tam S, Leung KS. Improved liquid chromatography–tandem mass spectrometry method in clinical utility for the diagnosis of Cushing’s syndrome. Anal Bioanal Chem 2010; 396: 783-790
    CrossrefPubMedGoogle Scholar
  • 47 Papanicolaou DA, Yanovski JA, Cutler Jr GB, Chrousos GP, Nieman LK. A single midnight serum cortisol measurement distinguishes Cushing’s syndrome from pseudo-Cushing states. J Clin Endocrinol Metab 1998; 83: 1163-1167
    CrossrefPubMedGoogle Scholar
  • 48 Reimondo G, Allasino B, Bovio S, Paccotti P, Angeli A, Terzolo M. Evaluation of the effectiveness of midnight serum cortisol in the diagnostic procedures for Cushing’s syndrome. Eur J Endocrinol 2005; 153: 803-809
    CrossrefPubMedGoogle Scholar
  • 49 Newell-Price J, Trainer P, Perry L, Wass J, Grossman A, Besser M. A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing’s syndrome. Clin Endocrinol (Oxf) 1995; 43: 545-550
    CrossrefPubMedGoogle Scholar
  • 50 Pecori Giraldi F, Ambrogio AG, De Martin M, Fatti LM, Scacchi M, Cavagnini F. Specificity of first-line tests for the diagnosis of Cushing’s syndrome: assessment in a large series. J Clin Endocrinol Metab 2007; 92: 4123-4129
    CrossrefPubMedGoogle Scholar
  • 51 Gorges R, Knappe G, Gerl H, Ventz M, Stahl F. Diagnosis of Cushing’s syndrome: re-evaluation of midnight plasma cortisol vs urinary free cortisol and low-dose dexamethasone suppression test in a large patient group. J Endocrinol Invest 1999; 22: 241-249
    PubMedGoogle Scholar
  • 52 Vilar L, Freitas MC, Naves LA, Canadas V, Albuquerque JL, Botelho CA, Egito CS, Arruda MJ, Silva LM, Arahata CM, Agra R, Lima LH, Azevedo M, Casulari LA. The role of non-invasive dynamic tests in the diagnosis of Cushing’s syndrome. J Endocrinol Invest 2008; 31: 1008-1013
    PubMedGoogle Scholar
  • 53 Grumbach MM, Biller BM, Braunstein GD, Campbell KK, Carney JA, Godley PA, Harris EL, Lee JK, Oertel YC, Posner MC, Schlechte JA, Wieand HS. Management of the clinically inapparent adrenal mass (“incidentaloma”). Ann Int Med 2003; 138: 424-429
    CrossrefPubMedGoogle Scholar
  • 54 Cronin C, Igoe D, Duffy MJ, Cunningham SK, McKenna TJ. The overnight dexamethasone test is a worthwhile screening procedure. Clin Endocrinol (Oxf) 1990; 33: 27-33
    CrossrefPubMedGoogle Scholar
  • 55 Montwill J, Igoe D, McKenna TJ. The overnight dexamethasone test is the procedure of choice in screening for Cushing’s syndrome. Steroids 1994; 59: 296-298
    CrossrefPubMedGoogle Scholar
  • 56 Wood PJ, Barth JH, Freedman DB, Perry L, Sheridan B. Evidence for the low dose dexamethasone suppression test to screen for Cushing’s syndrome – recommendations for a protocol for biochemistry laboratories. Ann Clin Biochem 1997; 34: 222-229
    PubMedGoogle Scholar
  • 57 Isidori AM, Kaltsas GA, Mohammed S, Morris DG, Jenkins P, Chew SL, Monson JP, Besser GM, Grossman AB. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab 2003; 88: 5299-5306
    CrossrefPubMedGoogle Scholar
  • 58 Barth JH, Seth J, Howlett TA, Freedman DB. A survey of endocrine function tests by clinical biochemistry laboratories in the UK. Ann Clin Biochem 1995; 32: 442-449
    PubMedGoogle Scholar
  • 59 Lin CL, Wu TJ, Machacek DA, Jiang NS, Kao PC. Urinary free cortisol and cortisone determined by high performance liquid chromatography in the diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab 1997; 82: 151-155
    CrossrefPubMedGoogle Scholar
  • 60 Morineau G, Gosling J, Patricot MC, Soliman H, Boudou P, al halnak A, Le Brun G, Brérault JL, Julien R, Villette JM, Fiet J. Convenient chromatographic prepurification step before measurement of urinary cortisol by radioimmunoassay. Clin Chem 1997; 43: 786-793
    PubMedGoogle Scholar
  • 61 Murphy BE. How much “UFC” is really cortisol?. Clin Chem 2000; 46: 793-794
    PubMedGoogle Scholar
  • 62 McCann SJ, Gillingwater S, Keevil BG. Measurement of urinary free cortisol using liquid chromatography-tandem mass spectrometry: comparison with the urine adapted ACS:180 serum cortisol chemiluminescent immunoassaay and development of a new reference range. Ann Clin Biochem 2005; 42: 112-118
    CrossrefPubMedGoogle Scholar
  • 63 Taylor RL, Machacek D, Singh RJ. Validation of a high-throughput liquid chromatography-tandem mass spectrometry method for urinary cortisol and cortisone. Clin Chem 2002; 48: 1511-1519
    PubMedGoogle Scholar
  • 64 Kushnir MM, Rockwood AL, Nelson GJ, Terry AH, Meikle AW. Liquid chromatography-tandem mass spectrometry analysis of urinary free cortisol. Clin Chem 2003; 49: 965-967
    CrossrefPubMedGoogle Scholar
  • 65 Ching SY, Lim EM, Beilby J, Bhagat C, Rossi E, Walsh JP, Pullan P. Urine free cortisol analysis by automated immunoassay and high-performance liquid chromatography for the investigation of Cushing’s syndrome. Ann Clin Biochem 2006; 43: 402-407
    CrossrefPubMedGoogle Scholar
  • 66 Kennedy DM, Selby C, Lawson N. Measurement of urinary free cortisol using the ACS:180 serum cortisol chemiluminescent immunoassay. Ann Clin Biochem 2000; 37: 520-528
    CrossrefPubMedGoogle Scholar
  • 67 Lamb EJ, Noonan KA, Burrin JM. Urine-free cortisol excretion: evidence of sex-dependence. Ann Clin Biochem 1994; 31: 455-458
    PubMedGoogle Scholar
  • 68 Palermo M, Shackleton CH, Mantero F, Stewart PM. Urinary free cortisone and the assessment of 11-beta-hydroxysteroid dehydrogenase activity in man. Clin Endocrinol (Oxf) 1996; 45: 605-611
    CrossrefPubMedGoogle Scholar
  • 69 Laudat MH, Cerdas S, Fournier C, Guiban D, Guilhaume B, Luton JP. Salivary cortisol measurement: a practical approach to assess pituitary-adrenal function. J Clin Endocrinol Metab 1988; 66: 343-348
    CrossrefPubMedGoogle Scholar
  • 70 Restituto P, Galofré JC, Gil MJ, Mugueta C, Santos S, Monreal JI, Varo N. Advantage of salivary cortisol measurements in the diagnosis of glucocorticoid related disorders. Clin Biochem 2008; 41: 688-692
    CrossrefPubMedGoogle Scholar